Suppr超能文献

间质干细胞治疗的进展与临床挑战。

Advances and clinical challenges of mesenchymal stem cell therapy.

机构信息

Department of Oncology, Tangdu Hospital, Air Force Medical University, Xi'an, China.

Department of Hematology, Tangdu Hospital, Air Force Medical University, Xi'an, China.

出版信息

Front Immunol. 2024 Jul 19;15:1421854. doi: 10.3389/fimmu.2024.1421854. eCollection 2024.

Abstract

In recent years, cell therapy has provided desirable properties for promising new drugs. Mesenchymal stem cells are promising candidates for developing genetic engineering and drug delivery strategies due to their inherent properties, including immune regulation, homing ability and tumor tropism. The therapeutic potential of mesenchymal stem cells is being investigated for cancer therapy, inflammatory and fibrotic diseases, among others. Mesenchymal stem cells are attractive cellular carriers for synthetic nanoparticles for drug delivery due to their inherent homing ability. In this review, we comprehensively discuss the various genetic and non-genetic strategies of mesenchymal stem cells and their derivatives in drug delivery, tumor therapy, immune regulation, tissue regeneration and other fields. In addition, we discuss the current limitations of stem cell therapy and the challenges in clinical translation, aiming to identify important development areas and potential future directions.

摘要

近年来,细胞疗法为有前途的新药提供了理想的特性。间充质干细胞由于其固有特性,包括免疫调节、归巢能力和肿瘤趋向性,成为开发基因工程和药物传递策略的有前途的候选物。间充质干细胞的治疗潜力正在被研究用于癌症治疗、炎症和纤维化疾病等。由于固有归巢能力,间充质干细胞是用于药物递送的合成纳米颗粒的有吸引力的细胞载体。在这篇综述中,我们全面讨论了间充质干细胞及其衍生物在药物输送、肿瘤治疗、免疫调节、组织再生等领域的各种遗传和非遗传策略。此外,我们还讨论了干细胞治疗的当前局限性和临床转化面临的挑战,旨在确定重要的发展领域和潜在的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/317a/11294097/270aedde23fa/fimmu-15-1421854-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验